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 Understanding the profile of physical activity and behaviour can allow targeting of rehabilitation interventions to address mobility and fitness.
Introduction
Charcot Marie Tooth disease (CMT) describes a group of hereditary neuropathies that present with distal weakness, wasting and sensory loss. These symptoms impact on physical activity [1] and functions such as walking [2] . The primary impairments lead to altered gait patterns, requiring compensatory strategies to achieve functional mobility [3] . It has been shown that walking is more effortful for people with CMT [4] [5] and this could contribute to reductions in physical activity.
Physical inactivity is implicated as a risk factor for developing a range of morbidities including obesity, cardiovascular disease, stroke, type-2 diabetes and osteoporosis [6] . Most forms of CMT do not alter life expectancy, so the prevention of co-morbidities is an important consideration in the long-term management of this disease [7] .
Small studies indicate that people with CMT have reduced daily activity levels. Accelerometers were used to quantify activities of daily living for eight people with CMT1A and eight matched controls over 24 hours [7] . No difference in step count was observed between the groups, but there were lower counts for stair climbing and sit to stand transitions. Knee extensor strength correlated positively with both activities. The aerobic capacity of people with CMT is reduced, with V0 2 max during exercise testing lower than normal values [8] [9] . This is an indicator of cardiovascular de-conditioning secondary to reduced physical activity.
The reasons for inactivity have had some exploration. A recent study used a mixed methods approach to explore facilitators and barriers to physical activity [10] using the Physical Activity Disability Survey. In addition, open ended questions were asked to identify barriers and facilitators in 44 people with CMT. The most active people tended to be younger, have greater self-efficacy, lower fatigue and greater balance confidence. Self-efficacy for physical activity and fatigue predicted 31% of the variance in physical activity on regression modelling. Key barriers related to impairments of physical functioning, including poor balance, muscle weakness and pain.
Study purpose: It is suggested that optimising physical activity should be part of a multi-factorial approach to improve societal participation in people with neuromuscular disease [11] . In order to embark on this, there must be a greater understanding of the patterns of activity observed in people with CMT. This study aimed to compare physical activity, patterns of sedentary behaviour and overall energy expenditure of people with CMT and healthy matched controls.
Materials and Methods
Subjects: Twenty individuals with CMT were recruited from genetic peripheral neuropathy clinics at the National Hospital for Neurology and Neurosurgery (NHNN) as part of another trial of a home exercise intervention [12] . Physical activity data collection took place during the control phase of the exercise trial, where participants were asked to continue with their normal routine and activities. Participants were included if they were aged 18-70 years, had a clinical diagnosis of CMT, or related condition, and were able to walk 50 metres with or without an aid.
Participants were excluded if they had another significant neurological disorder, major comorbidities, severe congenital hip dysplasia, or had undergone lower limb surgery in the six months prior to recruitment.
Data for twenty healthy control participants was extracted from a normative database, held at the MRC Muscle Performance and Training Laboratory (Movelab), Newcastle-upon-Tyne, and were matched for age and sex. Subjects included in the database were recruited from the Inland Revenue, Newcastle Council, Newcastle University employees and from an advert on a website. They were included if they had the ability to undertake physical activity monitoring for 7 days, were aged 18-70 years, had no heart complaints, or any other conditions that may affect day-to-day activity such as diabetes, chronic pain, heart, liver or neuromuscular disease.
All participants gave written informed consent, and a local research ethics committee gave the study approval before data collection began.
Physical activity measures: Physical activity was objectively measured using the SenseWear activity monitor (SenseWear Pro3, Bodymedia Inc, PA, USA), which is a validated multi-sensor device that incorporates skin temperature, galvanic skin response and bi-axial accelerometry with demographic information such as age, sex and body mass index (BMI) [13] . People with CMT underwent additional assessments, including a full medical history, physical status, gait performance and self-reported measures. Disease severity was scored by a neurologist using the CMT Examination Score [17] . Lower limb muscle strength was evaluated using the CITEC hand held dynamometer (C.I.T.Technics, Netherlands).
The following muscle groups were tested: hip extensors, hip abductors, hip adductors, hip flexors, knee extensors, knee flexors, plantarflexors, dorsiflexors. Walking endurance was measured using the six minute walk test [18] . Self-reported fatigue, walking ability and reported activity levels were measured in people with CMT using the Fatigue Severity Scale (FSS), Walk-12 and Phone- Unpaired two-tailed t-tests were performed to explore differences in activity variables and BMI between people with CMT and control participants. A secondary analysis using linear regression was used to explore predictors of activity variables, measured by the SenseWear activity monitor, from the clinical measures. All analyses were performed using STATA statistical software, version 13. All values are expressed as mean ± standard deviation (SD) unless otherwise stated.
Results:
Group Differences: Twenty people with CMT ( For the power law analysis, some errors in raw data export led to some missing data. Six records were lost from the CMT group and two from the control group. The remaining data was analysed and showed that transitions from being sedentary to active, relative to daily activity, time spent in moderate activity related to disease severity (CMTES), the walk-12 score and hip abductor strength (table 3) .
Discussion
The results of this study indicate a number of paradoxical findings. People with CMT expend the same amount of energy (calories and METs) as the matched controls, but take fewer steps per
day. An earlier study of activity monitoring [7] found no difference in step count, but this was only for eight people monitored over 24 hours. There will be a greater risk of bias due to the short duration and a small sample of a heterogeneous group. There is a suggestion, however, that greater effort and energy is expended when people with CMT walk [4] [5] . It is possible that this could account for the higher levels of energy expenditure, if we assume that walking is the main mode of activity. This is difficult to verify, however, plus there were no differences in the time spent in moderate activity.
An alternative explanation is that the algorithms used to calculate energy expenditure rely on anthropomorphic assumptions according to normal body composition. There is an estimation of the amount of muscle tissue, which is key to energy generation. People with CMT have significant levels of muscle wasting so there may be an over-estimation of energy expenditure. It is possible that they do expend less energy but the SenseWear activity monitor is not yet validated in people with CMT. That would require comparison with indirect calorimetry or doubly labelled water measurements to explore and quantify the shortfall.
The second paradoxical finding is that people with CMT have shorter bouts of sedentary activity and make more transitions from sedentary to active behaviours. This is despite fewer steps per day. This may be an indication that people with CMT move in other ways than just accumulating steps when walking, for example time spent in standing, however it is generally reported that people with CMT are a less physically active group. Frequent falls and poor balance are commonly reported problems and could be associated with limited walking [22] . People with CMT may break up sedentary periods with more frequent transitions into standing, without accumulating a larger number of steps, however this would require more detailed exploration with accelerometers that can distinguish between lying, sitting and standing. The sample for this study was taken from participants who volunteered for a trial of exercise training. It is possible that this was a more motivated and active group than the general CMT population in that they put themselves forward for the main study. This analysis would need repeating on another sample of people with CMT without the participation bias in order to see if this finding re-occurs.
The secondary analysis sought to observe whether clinical measures could predict levels of physical activity in the CMT sample. A higher BMI predicted lower MET expenditure and greater time spent sedentary. It is difficult to know at present which factor may have come first. Larger people may move less and be more sedentary, but it could also be these behaviours that contribute to higher BMI. If BMI is addressed through non exercise interventions, it would be interesting to see if changes in physical activity follow suit.
People with stronger hip abductor muscles expended more energy and spent more time in moderate activities. People with greater proximal strength will be less severely affected by CMT, so may find it easier to move more often. The CMTES measure of disease severity supports this in the prediction of moderate activity levels. A larger sample may demonstrate additional relationships with other muscle groups and may also reveal predictors of higher functioning individuals, of which there were few in this study.
Self-reported walking ability, measured by the walk-12 score, predicted greater calorie expenditure and time spent in moderate activity. This may indicate that the people who are more moderately active perceive a better ability to mobilise in general. There were no relationships identified for step count, vigorous activity levels and sedentary to active transitions.
This may have been due to the relatively small sample, but it could also be due to the limited parameters measured. Exploration of barriers to physical activity for people with CMT found that self-efficacy and balance confidence were significant factors [10] . These factors were not explored in this presented work and may have accounted for these variables. In particular, identifying the predictor of step count would have value in guiding targeting of physical activity interventions to improve overall mobility.
The sample for this study were heterogeneous genetically (table 1) , which introduces variability into the sample, but common patterns of impairment were noted. There were insufficient numbers in the rarer genetic groups to make meaningful comparisons, but the general presentation of distal muscle weakness was consistent in this sample.
Conclusion:
Physical activity monitoring of 20 people with CMT and 20 matched controls revealed that significantly fewer steps are taken by the CMT group, though clinical predictors were not identified. Paradoxically, the participants with CMT took shorter sedentary bouts and had more sedentary to active transitions than the control group that may have been non-walking activity.
There may have been a selection bias in this group as they volunteered for a study of exercise.
Further work needs to be done to validate the use of activity monitors in key activities due to assumptions that may not account for muscle wasting. In addition, a greater range of clinical measures need to be used to explore predictions of activity behaviours. 
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